Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature medicine 2024-06, Vol.30 (6), p.1784-1784
Hauptverfasser: Wadden, Thomas A., Chao, Ariana M., Machineni, Sriram, Kushner, Robert, Ard, Jamy, Srivastava, Gitanjali, Halpern, Bruno, Zhang, Shuyu, Chen, Jiaxun, Bunck, Mathijs C., Ahmad, Nadia N., Forrester, Tammy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1784
container_issue 6
container_start_page 1784
container_title Nature medicine
container_volume 30
creator Wadden, Thomas A.
Chao, Ariana M.
Machineni, Sriram
Kushner, Robert
Ard, Jamy
Srivastava, Gitanjali
Halpern, Bruno
Zhang, Shuyu
Chen, Jiaxun
Bunck, Mathijs C.
Ahmad, Nadia N.
Forrester, Tammy
description
doi_str_mv 10.1038/s41591-024-02883-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11186756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3069699729</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3901-971f26d0c7f3252d38a2aad9bb52b58425a2631fb9e797f1ed5aedb710486c573</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi0Eou3AC7BAltiwCfgSx3Y3qBq1FKlQCWYkdpaTnExcZeLBdqaaPgGPXbdTymXBwvLlfP9vH_8IvaLkHSVcvY8lFZoWhJV5KMUL-gQdUlFWBZXk-9O8JlIVSovqAB3FeEUI4UTo5-iAq5Joofkh-nkypd4HPPchQJOcH4_xwoUb2NjkWsC2SxCwGxOM0W0BD66DmHYD3J-FLYx3mrzBtp2GFPG1Sz32WwjX4FZ9wtnb1xBd2h3j1AP-tvz6-XL5ZVFwvOltBMxxCs4OL9Czzg4RXj7MM7Q8O13Mz4uLy4-f5icXRcM1oYWWtGNVSxrZcSZYy5Vl1ra6rgWrhSqZsKzitKs1SC07Cq2w0NaSklJVjZB8hj7sfTdTvYa2yQ0EO5hNcGsbdsZbZ_6ujK43K781lFJVSVFlh7cPDsH_mPJvmLWLDQyDHcFP0TDNWck5UTyjb_5Br_wUxtyf4aTSldYy0zPE9lQTfIwBusfXUGLukjb7pE1O2twnbWgWvf6zj0fJr2gzwPdAzKVxBeH33f-xvQW36LZb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3069699729</pqid></control><display><type>article</type><title>Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial</title><source>Nature</source><source>SpringerLink Journals - AutoHoldings</source><creator>Wadden, Thomas A. ; Chao, Ariana M. ; Machineni, Sriram ; Kushner, Robert ; Ard, Jamy ; Srivastava, Gitanjali ; Halpern, Bruno ; Zhang, Shuyu ; Chen, Jiaxun ; Bunck, Mathijs C. ; Ahmad, Nadia N. ; Forrester, Tammy</creator><creatorcontrib>Wadden, Thomas A. ; Chao, Ariana M. ; Machineni, Sriram ; Kushner, Robert ; Ard, Jamy ; Srivastava, Gitanjali ; Halpern, Bruno ; Zhang, Shuyu ; Chen, Jiaxun ; Bunck, Mathijs C. ; Ahmad, Nadia N. ; Forrester, Tammy</creatorcontrib><identifier>ISSN: 1078-8956</identifier><identifier>ISSN: 1546-170X</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/s41591-024-02883-1</identifier><identifier>PMID: 38409593</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>692/163/2743/393 ; 692/699/317 ; Author ; Author Correction ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Infectious Diseases ; Metabolic Diseases ; Molecular Medicine ; Neurosciences</subject><ispartof>Nature medicine, 2024-06, Vol.30 (6), p.1784-1784</ispartof><rights>The Author(s) 2024</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3901-971f26d0c7f3252d38a2aad9bb52b58425a2631fb9e797f1ed5aedb710486c573</citedby><orcidid>0009-0000-4712-3225 ; 0000-0002-1643-6795 ; 0000-0002-0438-4609</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41591-024-02883-1$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41591-024-02883-1$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38409593$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wadden, Thomas A.</creatorcontrib><creatorcontrib>Chao, Ariana M.</creatorcontrib><creatorcontrib>Machineni, Sriram</creatorcontrib><creatorcontrib>Kushner, Robert</creatorcontrib><creatorcontrib>Ard, Jamy</creatorcontrib><creatorcontrib>Srivastava, Gitanjali</creatorcontrib><creatorcontrib>Halpern, Bruno</creatorcontrib><creatorcontrib>Zhang, Shuyu</creatorcontrib><creatorcontrib>Chen, Jiaxun</creatorcontrib><creatorcontrib>Bunck, Mathijs C.</creatorcontrib><creatorcontrib>Ahmad, Nadia N.</creatorcontrib><creatorcontrib>Forrester, Tammy</creatorcontrib><title>Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial</title><title>Nature medicine</title><addtitle>Nat Med</addtitle><addtitle>Nat Med</addtitle><subject>692/163/2743/393</subject><subject>692/699/317</subject><subject>Author</subject><subject>Author Correction</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Infectious Diseases</subject><subject>Metabolic Diseases</subject><subject>Molecular Medicine</subject><subject>Neurosciences</subject><issn>1078-8956</issn><issn>1546-170X</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9kctu1DAUhi0Eou3AC7BAltiwCfgSx3Y3qBq1FKlQCWYkdpaTnExcZeLBdqaaPgGPXbdTymXBwvLlfP9vH_8IvaLkHSVcvY8lFZoWhJV5KMUL-gQdUlFWBZXk-9O8JlIVSovqAB3FeEUI4UTo5-iAq5Joofkh-nkypd4HPPchQJOcH4_xwoUb2NjkWsC2SxCwGxOM0W0BD66DmHYD3J-FLYx3mrzBtp2GFPG1Sz32WwjX4FZ9wtnb1xBd2h3j1AP-tvz6-XL5ZVFwvOltBMxxCs4OL9Czzg4RXj7MM7Q8O13Mz4uLy4-f5icXRcM1oYWWtGNVSxrZcSZYy5Vl1ra6rgWrhSqZsKzitKs1SC07Cq2w0NaSklJVjZB8hj7sfTdTvYa2yQ0EO5hNcGsbdsZbZ_6ujK43K781lFJVSVFlh7cPDsH_mPJvmLWLDQyDHcFP0TDNWck5UTyjb_5Br_wUxtyf4aTSldYy0zPE9lQTfIwBusfXUGLukjb7pE1O2twnbWgWvf6zj0fJr2gzwPdAzKVxBeH33f-xvQW36LZb</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Wadden, Thomas A.</creator><creator>Chao, Ariana M.</creator><creator>Machineni, Sriram</creator><creator>Kushner, Robert</creator><creator>Ard, Jamy</creator><creator>Srivastava, Gitanjali</creator><creator>Halpern, Bruno</creator><creator>Zhang, Shuyu</creator><creator>Chen, Jiaxun</creator><creator>Bunck, Mathijs C.</creator><creator>Ahmad, Nadia N.</creator><creator>Forrester, Tammy</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0009-0000-4712-3225</orcidid><orcidid>https://orcid.org/0000-0002-1643-6795</orcidid><orcidid>https://orcid.org/0000-0002-0438-4609</orcidid></search><sort><creationdate>20240601</creationdate><title>Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial</title><author>Wadden, Thomas A. ; Chao, Ariana M. ; Machineni, Sriram ; Kushner, Robert ; Ard, Jamy ; Srivastava, Gitanjali ; Halpern, Bruno ; Zhang, Shuyu ; Chen, Jiaxun ; Bunck, Mathijs C. ; Ahmad, Nadia N. ; Forrester, Tammy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3901-971f26d0c7f3252d38a2aad9bb52b58425a2631fb9e797f1ed5aedb710486c573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>692/163/2743/393</topic><topic>692/699/317</topic><topic>Author</topic><topic>Author Correction</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Infectious Diseases</topic><topic>Metabolic Diseases</topic><topic>Molecular Medicine</topic><topic>Neurosciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wadden, Thomas A.</creatorcontrib><creatorcontrib>Chao, Ariana M.</creatorcontrib><creatorcontrib>Machineni, Sriram</creatorcontrib><creatorcontrib>Kushner, Robert</creatorcontrib><creatorcontrib>Ard, Jamy</creatorcontrib><creatorcontrib>Srivastava, Gitanjali</creatorcontrib><creatorcontrib>Halpern, Bruno</creatorcontrib><creatorcontrib>Zhang, Shuyu</creatorcontrib><creatorcontrib>Chen, Jiaxun</creatorcontrib><creatorcontrib>Bunck, Mathijs C.</creatorcontrib><creatorcontrib>Ahmad, Nadia N.</creatorcontrib><creatorcontrib>Forrester, Tammy</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wadden, Thomas A.</au><au>Chao, Ariana M.</au><au>Machineni, Sriram</au><au>Kushner, Robert</au><au>Ard, Jamy</au><au>Srivastava, Gitanjali</au><au>Halpern, Bruno</au><au>Zhang, Shuyu</au><au>Chen, Jiaxun</au><au>Bunck, Mathijs C.</au><au>Ahmad, Nadia N.</au><au>Forrester, Tammy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial</atitle><jtitle>Nature medicine</jtitle><stitle>Nat Med</stitle><addtitle>Nat Med</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>30</volume><issue>6</issue><spage>1784</spage><epage>1784</epage><pages>1784-1784</pages><issn>1078-8956</issn><issn>1546-170X</issn><eissn>1546-170X</eissn><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>38409593</pmid><doi>10.1038/s41591-024-02883-1</doi><tpages>1</tpages><orcidid>https://orcid.org/0009-0000-4712-3225</orcidid><orcidid>https://orcid.org/0000-0002-1643-6795</orcidid><orcidid>https://orcid.org/0000-0002-0438-4609</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-8956
ispartof Nature medicine, 2024-06, Vol.30 (6), p.1784-1784
issn 1078-8956
1546-170X
1546-170X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11186756
source Nature; SpringerLink Journals - AutoHoldings
subjects 692/163/2743/393
692/699/317
Author
Author Correction
Biomedical and Life Sciences
Biomedicine
Cancer Research
Infectious Diseases
Metabolic Diseases
Molecular Medicine
Neurosciences
title Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A35%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Author%20Correction:%20Tirzepatide%20after%20intensive%20lifestyle%20intervention%20in%20adults%20with%20overweight%20or%20obesity:%20the%20SURMOUNT-3%20phase%203%20trial&rft.jtitle=Nature%20medicine&rft.au=Wadden,%20Thomas%20A.&rft.date=2024-06-01&rft.volume=30&rft.issue=6&rft.spage=1784&rft.epage=1784&rft.pages=1784-1784&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/s41591-024-02883-1&rft_dat=%3Cproquest_pubme%3E3069699729%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3069699729&rft_id=info:pmid/38409593&rfr_iscdi=true